Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome

Clinical Infectious Diseases

Volumn 36, Issue 1, 2003, Pages 70-78

  Fisk, David T ^a   Meshnick, Steven ^b   Kazanjian, Powel H ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b IL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; DAPSONE; PENTAMIDINE; PYRIMETH; STEROID; SULFADOX; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICA; ASIA; CENTRAL AMERICA; DEVELOPING COUNTRY; DISEASE ASSOCIATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INDUSTRIALIZATION; MAJOR CLINICAL STUDY; MORTALITY; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHILIPPINES; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; REVIEW; SOUTH AMERICA; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ASIA; CHILD; CHILD, PRESCHOOL; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HUMANS; INCIDENCE; MYCOBACTERIUM TUBERCULOSIS; PNEUMONIA, PNEUMOCYSTIS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 0037232716     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/344951     Document Type: Review

References (48)

1. Hughes WT. Pneumocystosis. In: Strickland GT, ed. Tropical medicine and emerging infectious diseases. Philadelphia: WB Saunders, 2000:701-4.
2. Walzer P. Pneumocystosis. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical infectious diseases: principles, pathogens, and practice. Philadelphia: Churchill Livingstone, 1999:673-84.
3. Colebunders R, Quinn T. Retroviruses and HIV. In: Warren KS, Mahmoud AAF, eds. Tropical and geographical medicine. New York: McGraw-Hill, 1990:728-41.
4. Lucas SB, Hounnou A, Peacock C, et al. The mortality and pathology of HIV infection in a West African City. AIDS 1993; 7:1569-79.
5. Malin AS, Gwanzura LKZ, Klein S, et al. Pneumocystis carinii pneumonia in Zimbabwe. Lancet 1995; 346:1258-61.
6. Zar HJ, Dechaboon A, Hanslo D, Apolles P, Magnus KG, Hussey G. Pneumocystis carinii pneumonia in South African children infected with human immunodeficiency virus. Pediatr Infect Dis J 2000; 19:603-7.
7. Graham SM, Mtitmila EI, Kamanga HS, Walsh AL, Hart CA, Molyneux ME. Clinical presentation and outcome of Pneumocystis carinii pneumonia in Malawain children. Lancet 2000; 355:369-73.
8. Kamiya Y, Mtitmila EL, Graham SM, Broadhead RL, Brabin B, Hart CA. Pneumocystis carinii pneumonia in Malawian children. Ann Trop Paed 1997; 17:121-6.
9. Ikeogu MO, Wolf B, Mathe S. Pulmonary manifestations in HIV seropositivity and malnutrition in Zimbabwe. Arch Dis Child 1997; 76:124-8.
10. Lucas SB, Peacock CS, Hounnou A, et al. Disease in children infected with HIV in Abidjan, Cote d'Ivoire. BMJ 1996; 312:335-8.
11. Jeena PM, Coovadia HM, Chrystal V. Pneumocystis and cytomegalovirus infections in severely ill, HIV-infected African infants. Ann Trop Paediatr 1996; 4:361-8.
12. Ruffini DD, Madhi SA. The high burden of Pneumocystis carinii pneumonia in African HIV-1-infected children hospitalized for severe pneumonia. AIDS 2002; 16:105-12.
13. Madhi SA, Petersen K, Madhi A, Khoosal M, Klugman KP. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in HIV type 1-infected children. Clin Infect Dis 2000; 31:170-6.
14. Lumbiganon P, Kosalaraksa P, Loapaiboon M. Survival of children with AIDS: experience in a university hospital in northeast Thailand. J Med Assoc Thai 2000; 83:652-6.
15. Bhoopat L, Thamprasert K, Chaiwun B, et al. Histopathologic spectrum of AIDS-associated lesions in Maharaj Nakorn Chiang Mai Hospital. Asian Pac J Allergy Immunol 1994; 12:95-104.
16. Mahomed AG, Murray J, Klempman GR, et al. Pneumocystis carinii pneumonia in HIV infected patients from South Africa. East Afr Med J 1999; 76:80-4.
17. Batungwanayo J, Taelman H, Lucas SB, et al. Pulmonary disease associated with HIV in Kigali, Rwanda. Am J Respir Crit Care Med 1994; 149:1591-6.
18. Atzori C, Bruno A, Chichino G, Gatti S, Scaglia M. Pneumocystis carinii pneumonia and tuberculosis in Tanzanian patients infected with HIV. Trans R Soc Trop Med Hyg 1993; 87:55-6
19. Machiels G, Urban MI. Pneumocystis carinii as a cause of pneumonia in HIV-infected patients in Lusaka, Zambia. Trans R Soc Trop Med Hyg 1992; 86:399-400.
20. Abouya YL, Beaumel A, Lucas SB, et al. Pneumocystis carinii pneumonia: an uncommon cause of death in African patients with acquired immune deficiency syndrome. Am Rev Respir Dis 1992; 145:617-20.
21. Carme B, Mboussa J, Andzin M, Mbouni E, Mpele P, Datry A. Pneumocystis carinii is rare in AIDS in Central Africa. Trans R Soc Trop Med Hyg 1991; 85:80-5.
22. McLeod DT, Neill P, Robertson VJ, et al. Pulmonary diseases in patients infected with the human immunodeficiency virus in Zimbabwe, Central Africa. Trans R Soc Trop Med Hyg 1989; 83:694-7.
23. Elvin KM, Lumbwe CM, Luo NP, Bjorkman A, Kallenius G, Linder E. Pneumocystis carinii is not a major cause of pneumonia in HIV-infected patients in Lukasa, Zambia. Trans R Soc Trop Med Hyg 1989; 83:553-5.
24. Tansuphasawadikul S, Amornkul PN, Tanchanpong C, et al. Clinical presentation of hospitalized adult patients with HIV infection and AIDS in Bangkok, Thailand. J Acquir Immune Defic Syndr 1999; 21:326-32.
25. Oh MD, Park SW, Kim HB, et al. Spectrum of opportunistic infections and malignancies in patients with human immunodeficiency virus infection in South Korea. Clin Infect Dis 1999; 29:1524-8.
26. Wannamethee SG, Sirivichayakul S, Phillips AN, et al. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand. Int J Epidemiol 1998; 27:289-95.
27. Hsiao CH, Huang SH, Huang SF, et al. Autopsy findings on patients with AIDS in Taiwan. J Microbiol Immunol Infect 1997; 30:145-59.
28. Mootsikapun P, Chetchotisakd P, Intarapoka B. Pulmonary infections in HIV infected patients. J Med Assoc Thai 1996; 79:477-85.
29. Manaloto CR, Perrault JG, Caringal LT, et al. Natural history of HIV infection in Filipino female commercial sex workers. J Acquir Immune Defic Syndr 1994; 7:1157-68.
30. Pitchenik AE, Fischl MA, Dickenson GM, et al. Opportunistic infections and Kaposi's sarcoma among Haitians: evidence of a new acquired immunodeficiency state. Ann Intern Med 1983; 98:277-84.
31. Serrano MT, Smith NH, Shandera WX. Epidemiology of human immunodeficiency virus infection in Central Americans treated in Harris County, Texas hospital district facilities. Am J Trop Med Hyg 1997; 57:678-82.
32. Rodriguez French A, Suarez M, Cornejo MX, de Iglesias MT, Roldan T. Pneumocistis carinii pneumonia in patients with AIDS at the Saint Thomas Hospital [in Spanish]. Rev Med Panama 1996; 21:4-10.
33. Mohar A, Romo J, Salido F, et al. The spectrum of clinical and pathological manifestations of AIDS in a consecutive series of autopsied patients in Mexico. AIDS 1992; 6:467-73.
34. + patients with and without access to antiretroviral therapy: survival and conclusions [abstract 85]. In: Program and abstracts of the 8th Conference on Retroviruses and Opportunistic Infections (Chicago). Alexandria, VA: Foundation for Retrovirology and Human Health 2001:31.
35. Santoro-Lopes G, Harrison LH, Moulton LH, et al. Gender and survival after AIDS in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 4:403-7.
36. Weinberg A, Duarte MIS. Respiratory complications in Brazilian patients infected with human immunodeficiency virus. Rev Inst Med Trop Sao Paulo 1993; 345:129-39.
37. Michalany J, Mattos AL, Michalany NS, et al. Acquired immune deficiency syndrome in Brazil: necropsy findings. Ann Pathol 1987; 7:15-24.
38. Moreira ED Jr, Silva N, Brites C, et al. Characteristics of the acquired immunodeficiency syndrome in Brazil. Am J Trop Med Hyg 1993; 48:687-92.
39. Narain JP, Raviglione M, Kochi A. HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tuber Lung Dis 1992; 73:311-21.
40. Lange JMA. HIV-related morbidity and mortality in sub-Saharan Africa: opportunities for prevention. AIDS 1993; 7:1675-6.
41. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced HIV infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338:853-60.
42. Ledergerber B, Egger B, Erard V, et al. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA 1999; 282:2220-6.
43. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. MMWR Morb Mortal Wkly Rep 1998; 9(2):28.
44. Del Amo J, Petruckevitch A, Phillips AN, et al. Spectrum of disease in Africans with AIDS in London. AIDS 1996; 10:1563-9.
45. Wiktor SZ, Sassan-Morokro MS, Grant AD, et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cote d'Ivoire: a randomised controlled trial. Lancet 1999; 353:1469-74.
46. Badri M, Erlich R, Wood R, Maartens G. Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations. AIDS 2001; 15:1143-8.
47. Anglaret X, Chene G, Attia A, et al. Early chemotherapy with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire: a randomised trial. Cotrimo-CI Study Group. Lancet 1999; 353:1463-8.
48. World Health Organization (WHO). WHO/UNAIDS hail consensus on use of cotrimoxazole for prevention of HIV-related infections in Africa. WHO press release 23. 5 April 2000. Available at: http://www.who.int/inf-pr-2000/en/pr2000-23.html. Accessed 10 December 2002.